Fosfluconazole for Antifungal Prophylaxis in Very Low Birth Weight Infants
We conducted a retrospective case series study to evaluate the safety of fosfluconazole prophylaxis for preventing invasive fungal infection in VLBW infants with a central vascular access. Fosfluconazole was administered intravenously at a dose of 6 mg/kg everyday during which time a central venous...
Saved in:
Main Authors: | Daijiro Takahashi, Tomohiko Nakamura, Reiko Shigematsu, Miyu Matsui, Shunsuke Araki, Kazuyasu Kubo, Hiroshi Sato, Akira Shirahata |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | International Journal of Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2009/274768 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparing Fluconazole and Nystatin as Antifungal Prophylactics in Very Low Birth Weight Infants: A Randomized Clinical Trial
by: Leila Asgarzadeh, et al.
Published: (2024-07-01) -
Iatrogenic pharyngoesophageal perforation in very low birth weight infants
by: Chung-Ming Chen
Published: (2025-01-01) -
The Post-Discharge Growth of Very Low Birth Weight Preterm Infants
by: Tuba Ozdemir, et al.
Published: (2020-08-01) -
Cardiac Troponin T and Illness Severity in the Very-Low-Birth-Weight Infant
by: Danielle N. Lopes, et al.
Published: (2012-01-01) -
Expanding diversity in developmental profiles of very-low-birth-weight infants during 6 years after birth
by: Kyoko Watanabe, et al.
Published: (2025-02-01)